M. PROTIVA
Impact in
- Organic Chemistry top 2%
- Chemical synthesis and alkaloids
- Synthesis and Biological Evaluation
- Synthesis and Reactions of Organic Compounds
- Asymmetric Synthesis and Catalysis
- Coordination Chemistry and Organometallics
- Synthesis and biological activity
- Toxicology top 5%
Papers in
-
- Synthesis and pharmacology of benzodiazepine derivatives 106
- Coordination Chemistry and Organometallics 79
- Asymmetric Synthesis and Catalysis 62
- Chemical Reaction Mechanisms 56
- Structural and Chemical Analysis of Organic and Inorganic Compounds 54
- Synthesis and Reactivity of Sulfur-Containing Compounds 50
- Chemical synthesis and alkaloids 49
- Co-authors
- Z. J. Vejdělek (61 shared papers)J. METYSOVA (107 shared papers)E. SVATEK (130 shared papers)J. O. Jílek (82 shared papers)J. HOLUBEK (125 shared papers)J Metys (47 shared papers)A Dlabac (51 shared papers)Ivo Jirkovsky (12 shared papers)
In The Last Decade
M. PROTIVA
314 papers receiving 924 citations
Peers
Comparison fields: 5 of 90
- Organic Chemistry 744
- Toxicology 45
- Spectroscopy 111
- Pharmaceutical Science 35
- Cellular and Molecular Neuroscience 103
Countries citing papers authored by M. PROTIVA
This map shows the geographic impact of M. PROTIVA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. PROTIVA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. PROTIVA more than expected).
Fields of papers citing papers by M. PROTIVA
This network shows the impact of papers produced by M. PROTIVA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. PROTIVA. The network helps show where M. PROTIVA may publish in the future.
Co-authors
The 25 scholars most cited alongside M. PROTIVA, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1961 | 46 | |
| 2 | 1979 | 22 | |
| 3 | 1984 | 19 | |
| 4 | 1969 | 16 | |
| 5 | 1965 | 16 | |
| 6 | 1965 | 15 | |
| 7 | 1991 | 15 | |
| 8 | 1964 | 15 | |
| 9 | 1990 | 14 | |
| 10 | 1962 | 13 | |
| 11 | 1961 | 13 | |
| 12 | 1959 | 12 | |
| 13 | 1968 | 11 | |
| 14 | 1957 | 11 | |
| 15 | 1960 | 11 | |
| 16 | 1968 | 10 | |
| 17 | 1964 | 10 | |
| 18 | 1968 | 10 | |
| 19 | 1989 | 10 | |
| 20 | 1972 | 9 |
About M. PROTIVA
M. PROTIVA is a scholar working on Organic Chemistry, Molecular Biology, Cellular and Molecular Neuroscience, Spectroscopy and Pharmaceutical Science, having authored 391 papers that have together received 1.0k indexed citations. Recurring topics across this work include Synthesis and pharmacology of benzodiazepine derivatives (106 papers), Coordination Chemistry and Organometallics (79 papers), Asymmetric Synthesis and Catalysis (62 papers), Chemical Reaction Mechanisms (56 papers), Structural and Chemical Analysis of Organic and Inorganic Compounds (54 papers), Neuroscience and Neuropharmacology Research (52 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (50 papers) and Chemical synthesis and alkaloids (49 papers). The work is most often cited by research in Organic Chemistry (744 citations), Toxicology (45 citations), Spectroscopy (111 citations), Pharmaceutical Science (35 citations) and Cellular and Molecular Neuroscience (103 citations). M. PROTIVA has collaborated with scholars based in Czechia, India and Canada. Frequent co-authors include Z. J. Vejdělek, J. METYSOVA, E. SVATEK, J. O. Jílek, J. HOLUBEK, J Metys, A Dlabac, Ivo Jirkovsky, B. Kakáč and Zdeněk Polívka. Their work appears in journals such as Die Naturwissenschaften, Cellular and Molecular Life Sciences, Tetrahedron Letters, Journal of Medicinal Chemistry and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.